Left ventricular function in patients with cardiorenal pathology and chronic renal failure
Abstract
Prognosis inpatients with pre-dialysis stages of chronic renal failure (CRF) is determined by various factors, including left ventricular hypertrophy (LVH) and coronary heart disease (CHD). At the same time, remodeling features and diastolic LV myocardial function in CRF patients are still understudied. The present study aimed to assess structural and functional LV features inpatients with early CRF stages and combined cardio-renal pathology. Among 70 patients with CHF and secondary arterial hypertension (AH), 35 also had CHD. According to clinical and echocardiography data, patients with combined cardio-renal pathology often had concentric and eccentric LVH types, as well as hypertrophic and pseudo-normal variants of LV diastolic dysfunction. Ln patients with CRF and symptomatic AH, eccentric LVH type or pseudo-normal diastolic dysfunction variant were not diagnosed. Chronic heart failure (CHF) symptoms in patients with CRF, secondary AH and CHD, were of systolo-diastolic nature; CHD-free participants had diastolic CHF.
About the Authors
M. M. Dudar
Кубанская государственная медицинская академия
Russian Federation
Russian Federation
A. V. Fendrikova
Кубанская государственная медицинская академия
Russian Federation
Russian Federation
A. K. Arutyunov
Адыгейский филиал Кубанской государственной медицинской академии
Russian Federation
Russian Federation
E. A. Kudryashov
Кубанская государственная медицинская академия
Russian Federation
Russian Federation
V. V. Skibitsky
Кубанская государственная медицинская академия
Russian Federation
Russian Federation
References
1. Визир В.А., Березин А.Е. Взаимосвязь процессов ремоделирования миокарда и нейрогуморальной активации у больных сердечной недостаточностью//Клиническая медицина. 2001. № 9. С. 21-27.
2. Дядык А.И., Багрий А.Э., Яровая Н.Ф. и др. Ишемическая болезнь сердца у больных с хронической почечной недостаточностью//Тер. архив. 1998. № 6. С. 74-77.
3. Томилина Н.А., Волгина Г.В. и др. Проблема сердечно-сосудистых заболеваний при хронической почечной недостаточности//Нефрология и диализ. 2003. Т. 5, № 1. С. 15-24.
4. Шестакова М.В. Нефропротекция: роль артериального давления в прогрессировании патологии почек. Зависит ли нефропротективный эффект от выбора антигипертензивного препарата? // Тер. архив. 2001. № 6. С. 64-66.
5. Швецов М.Ю. Блокаторы ангиотезина II -первый опыт и перспективы применения в нефрологии//Тер. архив. 2000. № 6. С. 22-26.
6. Abergel E., Tase M., Bohlader J. Which definition for echocardiography left ventricular hypertrophy?//Am. J. Cardiol. 1995. Vol. 75. P. 489-503.
7. Brunner E.P., Selwood N.H. on behalf of EDTA Registry Committee. Profile of patients on RRT in Europe and death rates due to major causes of death groups. Kidney Int. 1992; 42 Suppl. 38: 4-15.
8. Kannel W.B., Cobb J. Left ventricular hyperthrophy as a risk factor in arterial hypertension//Eur. Heart. J. 1992. Vol. 13. P. 82-88.
9. Parfrey P.S. Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management//Nephrol. Dial. Transplantant. 2000. Vol. 5. P. 56-68.
10. Rigatto C., Foley R.N., Parfrey P.S. et al. Long-term evolution of uremic cardiomioparty//J. Am. Soc. Nephrol. 1999. Vol. 10. P. 37-66.
Review
For citations:
Dudar M.M., Fendrikova A.V., Arutyunov A.K., Kudryashov E.A., Skibitsky V.V. Left ventricular function in patients with cardiorenal pathology and chronic renal failure. Russian Journal of Cardiology. 2006;(3):26-29. (In Russ.)
Views:
388
Email this article 